Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Barrett Esophagus 13Stomach Neoplasms 8Adenocarcinoma Of Esophagus 6Gastroesophageal Reflux 4Gastritis, Atrophic 4Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Adenomatous Polyposis Coli 2Weight Loss 1Thrombocythemia, Essential 1Stomach Ulcer 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Mantle-Cell 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Fibrosis 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Duodenal Neoplasms 1Deglutition Disorders 1Colorectal Neoplasms 1Cholangiocarcinoma 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

Rituximab 226Cyclophosphamide 202fludarabine phosphate 108Peripheral Blood Stem Cell Transplantation 103Filgrastim 87Etoposide 76Cytarabine 70ibrutinib 68Mycophenolic Acid 67Bortezomib 66Whole-Body Irradiation 63Cyclosporine 63Melphalan 59Lenalidomide 59Bendamustine Hydrochloride 58Vincristine 53Radiotherapy 53fludarabine 52Tacrolimus 50Doxorubicin 48Busulfan 48Methotrexate 47Antilymphocyte Serum 42Prednisone 41Carmustine 40Dexamethasone 38Granulocyte Colony-Stimulating Factor 33venetoclax 32acalabrutinib 31zanubrutinib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Endoscopy, Digestive System × Clear all
NCT05976763 2026-06-02

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
421 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡